Biotech · Public company · Boston, MA, US
Avalyn Pharma Inc.
Ticker AVLN · SEC CIK 0001540171
Track this companyFree. Adds Avalyn Pharma Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- AP01Phase 2 · Progressive Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- AP01Phase 2 · Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)PHASE2 · RECRUITING · started Apr 17, 2025ClinicalTrials.gov NCT06951217 · fetched Nov 12, 2026
- A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 3, 2024ClinicalTrials.gov NCT06329401 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 16, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 17, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jun 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
- 424B4 · 424B4SEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Apr 29, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Apr 23, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Apr 8, 2026 · fetched Nov 12, 2026